Dr. Johnson joined the hospital in 2002. Previously, she served as deputy director and chair of the department of pharmacology and therapeutics, a position she will maintain. In addition, Dr. Johnson serves as Cancer Center Director, the Wallace Family chair for translational research and professor of oncology.
Dr. Johnson succeeds Donald Trump, MD, who resigned last fall and became CEO of Inova Comprehensive Cancer and Research Institute in Fairfax, Va., in January.
More articles on hospital and health system executive moves:
Rulon Stacey to step down as CEO of Fairview Health
Halifax Health board chairman resigns after failed attempt to fire CEO
Presence St. Joseph Medical Center CEO Beth Hughes resigns
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.